NEOS THERAPEUTICS INC's ticker is NEOS and the CUSIP is 64052L106. A total of 39 filers reported holding NEOS THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 0.10 and the average weighting 0.1%.
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
DSC Advisors, L.P. | 784,704 | $5,163,000 | 3.14% |
WALL STREET ASSOCIATES | 149,343 | $983,000 | 0.34% |
DAFNA Capital Management LLC | 38,873 | $256,000 | 0.18% |
Perceptive Advisors | 330,593 | $2,175,000 | 0.14% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 229,166 | $1,508,000 | 0.07% |
FALCON POINT CAPITAL, LLC | 69,135 | $408,000 | 0.06% |
Cormorant Asset Management, LP | 50,613 | $333,000 | 0.04% |
BRIDGEWAY CAPITAL MANAGEMENT, LLC | 80,000 | $526,000 | 0.01% |
FRANKLIN RESOURCES INC | 1,314,700 | $8,650,000 | 0.01% |
PUTNAM INVESTMENTS LLC | 215,000 | $1,415,000 | 0.00% |